Time for a New Approach to Studying Older People with Ischemic Heart Disease.
作者信息
Dodson John A, Chaudhry Sarwat I, Krumholz Harlan M
机构信息
Leon H. Charney Division of Cardiology, Department of Medicine, School of Medicine, New York University, New York City, New York.
Division of Healthcare Delivery Science, Department of Population Health, School of Medicine, New York University, New York City, New York.
出版信息
J Am Geriatr Soc. 2017 Nov;65(11):2349-2351. doi: 10.1111/jgs.14923. Epub 2017 May 11.
Abstract
摘要
相似文献
1
Time for a New Approach to Studying Older People with Ischemic Heart Disease.是时候采用新方法研究老年缺血性心脏病患者了。
J Am Geriatr Soc. 2017 Nov;65(11):2349-2351. doi: 10.1111/jgs.14923. Epub 2017 May 11.
2
Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease.老年人群被排除在缺血性心脏病药物随机临床试验之外。
J Am Geriatr Soc. 2017 Nov;65(11):2354-2361. doi: 10.1111/jgs.14833. Epub 2017 Mar 17.
3
Pursuit of Myocardial Ischemia for Therapeutic Decision-Making in Patients With Diabetes and Stable Ischemic Heart Disease: Reconciling Randomized Controlled Trials and Observational Studies.在糖尿病和稳定型缺血性心脏病患者中进行心肌缺血检测以指导治疗决策：协调随机对照试验与观察性研究
Diabetes Care. 2022 Dec 1;45(12):2823-2827. doi: 10.2337/dci22-0035.
4
The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?心肌灌注成像在稳定型缺血性心脏病中难以捉摸的作用：“缺血性心脏病范围和预后评估（ISCHEMIA）试验”是答案吗？
J Nucl Cardiol. 2017 Oct;24(5):1610-1618. doi: 10.1007/s12350-017-0963-3. Epub 2017 Jul 27.
5
Is ischemia the most powerful indicator of myocardial viability?缺血是心肌活力的最强指标吗？
Curr Cardiol Rep. 2013 May;15(5):354. doi: 10.1007/s11886-013-0354-6.
6
Ivabradine significantly improves cardiac function in patients with ischemic heart disease: a meta-analysis of randomized controlled trials.伊伐布雷定可显著改善缺血性心脏病患者的心功能：一项随机对照试验的荟萃分析。
Int J Cardiol. 2013 Oct 3;168(3):3007-10. doi: 10.1016/j.ijcard.2013.04.061. Epub 2013 May 4.
7
[Ischemic heart disease in the elderly. Special Conference of the 36th National Congress of the Spanish Society of Cardiology].[老年人缺血性心脏病。西班牙心脏病学会第36届全国大会特别会议]
Rev Esp Cardiol. 2001 Jul;54(7):819-26. doi: 10.1016/s0300-8932(01)76405-6.
8
Ischemia-guided myocardial revascularization: the oculo-ischemic reflex.缺血引导的心肌血运重建：眼缺血反射
Arq Bras Cardiol. 2014 Apr;102(4):e40. doi: 10.5935/abc.20140047.
9
Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).冠心病合并缺血性心肌病患者接受药物或手术治疗的随机对照预后评估的假设、理论依据、设计及方法：MASS-VI（心力衰竭）研究
Trials. 2020 Apr 16;21(1):337. doi: 10.1186/s13063-020-04270-w.
10
Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.成人骨髓细胞疗法治疗缺血性心脏病：来自随机对照试验的证据与见解
Circ Res. 2015 Aug 28;117(6):558-75. doi: 10.1161/CIRCRESAHA.114.304792. Epub 2015 Jul 9.
引用本文的文献
1
Optimal anti-platelet therapy for older patients with acute coronary syndrome: a network meta-analysis of randomized trials comprising 59,284 older patients.老年急性冠状动脉综合征患者的最佳抗血小板治疗：包含 59284 例老年患者的随机试验的网络荟萃分析。
J Thromb Thrombolysis. 2024 Jan;57(1):143-154. doi: 10.1007/s11239-023-02875-x. Epub 2023 Aug 7.
2
Variation in propofol induction doses administered to surgical patients over age 65.在 65 岁以上的手术患者中，异丙酚诱导剂量的变化。
J Am Geriatr Soc. 2021 Aug;69(8):2195-2209. doi: 10.1111/jgs.17139. Epub 2021 Mar 31.
3
Patient and Cardiologist Perspectives on Shared Decision Making in the Treatment of Older Adults Hospitalized for Acute Myocardial Infarction.患者和心脏病专家对老年急性心肌梗死住院患者治疗中共同决策的看法。
Med Decis Making. 2020 Apr;40(3):279-288. doi: 10.1177/0272989X20912293.
4
Improving Care Using a Bidirectional Geriatric Cardiology Consultative Conference.双向老年心脏病学咨询会议改善护理。
J Am Geriatr Soc. 2018 Jul;66(7):1415-1419. doi: 10.1111/jgs.15356. Epub 2018 Mar 15.
本文引用的文献
1
Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease.老年人群被排除在缺血性心脏病药物随机临床试验之外。
J Am Geriatr Soc. 2017 Nov;65(11):2354-2361. doi: 10.1111/jgs.14833. Epub 2017 Mar 17.
2
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.强化与标准血压控制对≥75岁成年人心血管疾病结局的影响：一项随机临床试验。
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
3
Older Adults in Clinical Research and Drug Development: Closing the Geriatric Gap.临床研究与药物研发中的老年人：弥合老年差距
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):631-3. doi: 10.1161/CIRCOUTCOMES.115.002158. Epub 2015 Oct 20.
4
The ADAPTABLE Trial and PCORnet: Shining Light on a New Research Paradigm.ADAPTABLE试验与PCORnet：照亮一种新的研究范式。
Ann Intern Med. 2015 Oct 20;163(8):635-6. doi: 10.7326/M15-1460. Epub 2015 Aug 25.
5
Design and rationale of the comprehensive evaluation of risk factors in older patients with AMI (SILVER-AMI) study.老年急性心肌梗死患者危险因素综合评估（SILVER-AMI）研究的设计与原理
BMC Health Serv Res. 2014 Nov 5;14:506. doi: 10.1186/s12913-014-0506-4.
6
INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY).强化与标准门诊血压降低以预防老年人功能下降（INFINITY）。
Am Heart J. 2013 Mar;165(3):258-265.e1. doi: 10.1016/j.ahj.2012.11.008. Epub 2013 Jan 5.
7
Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions.在2011年美国心脏协会科学会议的最新临床试验中老年人的代表性。
J Am Coll Cardiol. 2012 Aug 28;60(9):869-71. doi: 10.1016/j.jacc.2012.03.034. Epub 2012 May 30.
8
The impact of the aging population on coronary heart disease in the United States.人口老龄化对美国冠心病的影响。
Am J Med. 2011 Sep;124(9):827-33.e5. doi: 10.1016/j.amjmed.2011.04.010. Epub 2011 Jun 30.
9
The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.老年患者持续被排除在关于心力衰竭的正在进行的临床试验之外。
Arch Intern Med. 2011 Mar 28;171(6):550-6. doi: 10.1001/archinternmed.2011.31.
10
Views of older persons with multiple morbidities on competing outcomes and clinical decision-making.患有多种疾病的老年人对相互竞争的结果和临床决策的看法。
J Am Geriatr Soc. 2008 Oct;56(10):1839-44. doi: 10.1111/j.1532-5415.2008.01923.x. Epub 2008 Sep 2.
Zotero 插件